SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001626199-21-000101
Filing Date
2021-08-10
Accepted
2021-08-10 16:21:07
Documents
5
Effectiveness Date
2021-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 s-8_2021inducementaward.htm S-8 92227
2 EX-4.4 alpn-ex44_20210810.htm EX-4.4 108516
3 EX-5.1 alpn-ex51_20210810.htm EX-5.1 7357
4 EX-23.1 forms-8consent.htm EX-23.1 2279
5 image_0.jpg GRAPHIC 68421
  Complete submission text file 0001626199-21-000101.txt   303813
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-258674 | Film No.: 211160219
SIC: 2834 Pharmaceutical Preparations